Quest Diagnostics (DGX) Stock Could Be Undervalued Despite Raised Full Year Guidance

Quest Diagnostics has delivered a strong share price run in recent years, and fresh headlines about product expansion and digital health tie-ups keep interest high. With the stock now reflecting years of gains, the open question is whether the business's cash flows are enough to justify where the valuation sits today. Over the past 3 years, Quest Diagnostics has returned 96.2%, which puts a lot of focus on whether its cash generation can continue to support that kind of share price...